4-(diethylamino)-benzenesulphonyl chloride | 90945-15-6

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(diethylamino)-benzenesulphonyl chloride
• 英文别名: 4-diethylaminobenzenesulfonyl chloride；4-(N,N-diethylamino)benzenesulfonyl chloride；4-diethylaminobenzenesulphonyl chloride；4-Diethylamino-benzol-sulfonylchlorid-(1)；4-(diethylamino)benzenesulfonyl chloride
• CAS: 90945-15-6
• 化学式: C₁₀H₁₄ClNO₂S
• mdl: MFCD19200153
• 分子量: 247.746
• InChiKey: USMOFKMCIDJIBZ-UHFFFAOYSA-N

物化性质

• 沸点：
  348.0±25.0 °C(Predicted)
• 密度：
  1.256±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  15
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  45.8
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(diethylamino)-benzenesulphonyl chloride 在 碳酸氢钠 作用下， 以 二氯甲烷 为溶剂， 反应 18.5h， 生成 (E,E)-4-methyl-5-{4-[4-(diethylamino)phenyl]sulfonamido}penta-2,4-dienoic acid trifluoroacetate
  参考文献：
  名称：

  WO2008/50125

  摘要：

  公开号：
• 作为产物：
  描述：

  N,N-二乙基苯胺 在 三甲基甲硅烷 、 五氯化磷 作用下， 生成 4-(diethylamino)-benzenesulphonyl chloride
  参考文献：
  名称：

  WO2008/50125

  摘要：

  公开号：

文献信息

• Derivatives of 1-arylsulphonyl-2-pyrrolidinone and their use as
  申请人：Roussel Uclaf

  公开号：US04990531A1

  公开（公告）日：1991-02-05

  Compounds useful for the treatment of patients suffering from muscle spasms of the formula (I) ##STR1## in which R represents the radical ##STR2## in which R.sub.1, in any position on the phenyl nucleus, represents a linear, branched or cyclic alkyl, alkenyl or alkynyl, containing up to 8 carbon atoms, or the radical ##STR3## in which R.sub.2 and R.sub.3, identical or different each represents a hydrogen atom, a linear alkyl, alkenyl or alkynyl, containing up to 8 carbon atoms, or form together with the nitrogen atom to which they are joined, a heterocyclic radical optionally containing another heteroatom, or NO.sub.2, or OR', R' representing hydrogen, a linear, branched or cyclic alkyl containing up to 8 carbon atoms, or aryl containing up to 14 carbon atoms, or an SR.sub.4 or S(O)R.sub.5 radical, R.sub.4 and R.sub.5 representing a linear, branched or cyclic alkyl, alkenyl or alkynyl, containing up to 8 carbon atoms, or R represents naphthyl, optionally substituted by an R.sub.1 radical, as defined above; also therapeutic compositions containing the same and method of use.

  用于治疗患有肌肉痉挛的化合物的公式(I) ##STR1## 中，其中R代表基团##STR2##，其中R.sub.1，在苯核上的任何位置，代表含有最多8个碳原子的直链、支链或环烷基、烯基或炔基，或基团##STR3##，其中R.sub.2和R.sub.3，相同或不同，每个代表氢原子、含有最多8个碳原子的直链烷基、烯基或炔基，或与它们连接的氮原子一起形成一个可能含有另一个杂原子的杂环基，或NO.sub.2，或OR'，其中R'代表氢、含有最多8个碳原子的直链、支链或环烷基，或含有最多14个碳原子的芳基，或SR.sub.4或S(O)R.sub.5基团，其中R.sub.4和R.sub.5代表含有最多8个碳原子的直链、支链或环烷基、烯基或炔基，或R代表萘基，可选择地由上述定义的R.sub.1基团取代；还包括含有相同化合物的治疗组合物和使用方法。
• 1-arylsulphonyl-2-pyrrolidinethione or
  申请人：Roussel-Uclaf

  公开号：US05037822A1

  公开（公告）日：1991-08-06

  The invention relates to the products of formula ##STR1## in which R represents the radical ##STR2## in which R.sub.1 at any position on the benzene ring represents a linear, branched or cyclic alkyl, alkenyl or alkynyl containing up to 8 carbon atoms, or the radical ##STR3## in which R.sub.2 and R.sub.3, which may be identical or different, represent a hydrogen atom or a linear alkyl, alkenyl or alkynyl containing up to 8 carbon atoms or form, together with the nitrogen atom to which they are attached, a carbonaceous heterocyclic radical optionally containing another hetero form, or the radical OR', R' representing hydrogen, a linear, branched or cyclic alkyl radical containing up to 8 carbon atoms or an aryl radical containing up to 14 carbon atoms, or the radical SR.sub.4 or S(O)R.sub.5, R.sub.4 and R.sub.5 representing a linear, branched or cyclic alkyl, alkenyl or alkynyl containing up to 8 carbon atoms, or R represents naphthyl optionally substituted with a radical R'.sub.1, R'.sub.1 having one of the definitions stated above for R.sub.1, and n represents the number 1 or number 2, to a process for the preparation thereof, to their application as medicinal products and to compositions containing them.

  该发明涉及公式##STR1##的产品，其中R代表基团##STR2##，其中苯环上的任意位置的R.sub.1代表线性、支链或环状烷基、烯基或炔基，含有最多8个碳原子，或基团##STR3##，其中R.sub.2和R.sub.3，可以相同也可以不同，代表氢原子或含有最多8个碳原子的线性烷基、烯基或炔基，或与它们连接的氮原子一起形成一个含有另一个杂原子的碳杂环基，或基团OR'，其中R'代表氢、含有最多8个碳原子的线性、支链或环状烷基基团，或含有最多14个碳原子的芳基基团，或基团SR.sub.4或S(O)R.sub.5，其中R.sub.4和R.sub.5代表含有最多8个碳原子的线性、支链或环状烷基、烯基或炔基，或R代表萘，可选地与基团R'.sub.1取代，R'.sub.1具有上述R.sub.1的定义，并且n代表数字1或数字2，涉及其制备方法，其作为药物产品的应用以及包含它们的组合物。
• 1-arylsulphonyl-2-piperidinone derivatives, process and intermediates
  申请人：Roussel Uclaf

  公开号：US05041436A1

  公开（公告）日：1991-08-20

  The invention relates to the products of formula ##STR1## in which R represents the radical ##STR2## in which R.sub.1 at any position on the benzene ring represents linear, branched or cyclic alkyl, alkenyl or alkynyl containing up to 8 carbon atoms, or the radical ##STR3## in which R.sub.2 and R.sub.3, which may be identical or different, represents hydrogen or linear alkyl, alkenyl or alkynyl containing up to 8 carbon atoms or form, together with the nitrogen atom to which they are attached, a carbonaceous heterocyclic radical optionally containing another hetero atom, or the radical OR', R' representing hydrogen, a linear, branched or cyclic alkyl containing up to 8 carbon atoms or aryl containing up to 14 carbon atoms, or the radical SR.sub.4 or S(O)R.sub.5, R.sub.4 and R.sub.5 representing linear, branched or cyclic alkyl, alkenyl, or alkynyl containing up to 8 carbon atoms, or R represents naphthyl optionally substituted with the radical R'.sub.1, R'.sub.1 being as defined above for R.sub.1, to a process and intermediates for the preparation thereof, to their application as medicinal products and to compositions containing them.

  本发明涉及公式##STR1##的产物，其中R代表基团##STR2##，其中苯环上任何位置的R.sub.1代表直链，支链或环状烷基，烯基或炔基，含有高达8个碳原子，或基团##STR3##，其中R.sub.2和R.sub.3可以相同或不同，代表氢或直链烷基，烯基或炔基，含有高达8个碳原子，或与它们连接的氮原子一起形成碳杂环基团，可选含有另一个杂原子，或基团OR'，其中R'代表氢，含有高达8个碳原子的直链，支链或环状烷基，或含有高达14个碳原子的芳基，或基团SR.sub.4或S（O）R.sub.5，其中R.sub.4和R.sub.5代表直链，支链或环状烷基，烯基或炔基，含有高达8个碳原子，或R代表萘，可选用基团R'.sub.1取代，其中R'.sub.1与R.sub.1的定义相同，本发明还涉及其制备过程和中间体，以及它们作为药物产品和含有它们的组合物的应用。
• COMPOUNDS AND USES THEREOF
  申请人：Aboagye Eric Ofori

  公开号：US20100063144A1

  公开（公告）日：2010-03-11

  There is provided a compound of formula (I) wherein R 1a , R 2a , R 3 , X 1 to X 6 , a, b and c have meanings given in the description, which compounds are useful as, or are useful as prodrugs of, inhibitors of HDAC enzyme activity, and thus, in particular, in the treatment of conditions where inhibition of HDAC enzyme activity is required.

  提供了一种化合物，其分子式为(I)，其中R1a，R2a，R3，X1至X6，a，b和c的含义在描述中给出，这些化合物可用作HDAC酶活性的抑制剂，或者可用作其前药，因此特别适用于需要抑制HDAC酶活性的疾病的治疗。
• Toja; Parini; Bonetti, Arzneimittel-Forschung/Drug Research, 1994, vol. 44, # 4, p. 501 - 509
  作者：Toja、Parini、Bonetti、Hunt、Fortin、Barzaghi、Cesana、Maggioni、Nencioni、Galliani

  DOI：——

  日期：——